Inari Medical, Inc. (NARI)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Inari Medical, Inc. (NARI)
Go deeper and ask any question about NARI
Company Performance
Current Price
as of Oct 04, 2024$41.92
P/E Ratio
N/A
Market Cap
$2.44B
Description
Inari Medical, Inc. operates as a medical device company. The firm develops, manufactures, markets and sells devices for the interventional treatment of venous diseases. Its products include FlowTriever system and ClotTriever system. The company was founded by Brian J. Cox, Paul Lubock and Robert F. Rosenbluth in June 2011 and is headquartered in Irvine, CA.
Metrics
Overview
- HQIrvine, CA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerNARI
- Price$41.92+0.75%
Trading Information
- Market Cap$2.44B
- Float85.37%
- Average Daily Volume (1m)830,710
- Average Daily Volume (3m)899,663
- EPS-$0.98
Company
- Revenue$547.47M
- Rev Growth (1yr)22.53%
- Net Income-$31.35M
- Gross Margin83.86%
- EBITDA Margin-7.50%
- EBITDA-$10.94M
- EV$2.72B
- EV/Revenue4.97
- P/EN/A
- P/S4.45
Documents
SEC Filings
Earnings Calls
Factset Street Account